Overview
Abi Global Health provides B2B2C on-demand virtual healthcare by embedding an AI-powered telemedicine platform into clients’ apps or websites, or into messaging channels like WhatsApp and SMS. The platform uses natural language processing to understand health questions, then matches the patient with the best available doctor, nurse, or specialist for micro-consultations, scheduled voice/video visits, mental health reviews, or prescriptions. It differentiates itself by integrating with existing client products to boost user engagement and reduce costs within provider networks, serving payers such as insurers, pharma companies, and digital health providers in over 40 countries. Its goal is to make healthcare easier to access, more consistent, and more cost-efficient by bundling telemedicine services with clients’ offerings.
Work here?Claim your company
Simplify's take
What believers are saying
- Riverside Acceleration Capital invested on September 3, 2026, adding fresh capital.
- Abi claims top-five global pharma and insurance clients, signaling enterprise credibility.
- Revelio shows 73 employees in June 2026, and hiring remained active.
What critics are saying
- Revelio shows headcount fell 9.5% from 2023 to 2026, signaling restraint.
- Active job postings dropped 92.3% in 2026, limiting product and sales execution.
- A lost insurer or pharma anchor could crush usage-based revenue and force retrenchment.
What makes Abi Global Health unique
- Abi embeds care inside client apps, WhatsApp, Telegram, and SMS, reducing patient friction.
- Its AI triages requests to licensed clinicians, blending automation with human care.
- Riverside Acceleration Capital invested September 2026, validating the B2B2C model.
Help us improve and share your feedback! Did you find this helpful?